On the recordSeptember 29, 2020
the FDA very specifically said that they did not think that providing samples to generic manufacturers would create a safety concern.
Source
congress.govEditor's note · Context
Wasserman Schultz criticizes Celgene's tactics to delay generic drug access.
Share
More from Debbie Wasserman Schultz
Jul 27, 2026
This change will significantly impede efforts to protect and conserve our nation’s threatened and endangered species of fish, wildlife and plants.
Feb 25, 2025
I thank the gentleman for yielding. Mr. Speaker, I rise to oppose the Republican budget resolution that utterly betrays middle-class Americans and threatens to explode the deficit. This deceitful budget would gut Medicaid, schools, and…
Jul 27, 2026
The rule change directly threatens the unique habitats that support the plants and animals for which our state is renowned.
Jul 9, 2025
To not be willing to condemn the term ‘globalize the intifada,’ it just demonstrates his callous disregard for antisemitism, terrorist activity.
Other voices in this conversation
